高等学校化学学报 ›› 2018, Vol. 39 ›› Issue (10): 2185.doi: 10.7503/cjcu20180181

• 分析化学 • 上一篇    下一篇

基于部分还原氧化石墨烯纳米复合材料的肿瘤靶向光动力-光热联合治疗剂的制备

王雪丽1,2, 王振新2()   

  1. 1. 吉林工商学院粮食学院, 长春 130507
    2. 中国科学院长春应用化学研究所, 电分析化学国家重点实验室, 长春 130022
  • 收稿日期:2018-02-07 出版日期:2018-09-29 发布日期:2018-09-29
  • 作者简介:

    联系人简介: 王振新, 男, 博士, 研究员, 博士生导师, 主要从事生物芯片研究和纳米粒子在多模态成像中的应用研究. E-mail: wangzx@ciac.ac.cn

  • 基金资助:
    国家自然科学基金(批准号: 21475126, 21775145)资助.

Preparation of a Targeted Tumor Nanocomposites for Combined Photodynamic-photothermal Therapy Based on Partially Reduced Graphene Oxide

WANG Xueli1,2, WANG Zhenxin2,*()   

  1. 1. Grain College, Jilin Business and Technology College, Changchun 130507, China
    2. State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry Chinese Academy of Science, Changchun 130022, China
  • Received:2018-02-07 Online:2018-09-29 Published:2018-09-29
  • Contact: WANG Zhenxin E-mail:wangzx@ciac.ac.cn
  • Supported by:
    † Supported by the National Science Foundation of China(Nos.21475126, 21775145).

摘要:

以氧化石墨烯(GO)为原料, 通过温和方法制备部分还原氧化石墨烯(pRGO); 由pRGO与核酸适配体 AS1411 及吲哚菁绿(ICG)通过非共价作用构建了光热-光敏纳米复合物 pRGO-AS1411-ICG(pRAI). 利用傅里叶变换红外光谱(FTIR)、 拉曼光谱(Raman)、 X射线光电子能谱(XPS)、 紫外-可见光谱、 透射电子显微镜和 EDS 能谱对 pRGO 和 pRAI 复合物的结构和形貌进行了表征, 并利用细胞实验考察了其肿瘤细胞的光疗-热疗效果. 结果表明, pRAI 以 AS1411 为靶向分子, 可通过光热和光毒性双重作用高效杀伤肿瘤细胞.

关键词: 部分还原氧化石墨烯, 纳米复合材料, 光热疗法, 光动力学疗法, 肿瘤细胞

Abstract:

Partially reduced grphene oxide(pRGO) is synthesized using a mild reduction method by incubating GO suspension under alkaline condition at room tempeature. Aptamer(AS1411) non-covalent binding with cardiogreen(ICG), a photosensitizer and photothermal effect molecule, to the surface of pRGO, was used to target cancer cells for photodynamic therapy(PDT) and photothermal therapy(PTT). Structure and morphology of the as-synthesized pRGO and pRGO-AS1411-ICG(pRAI) nanocomposites were confirmed by menas of FTIR, Raman, XPS, UV-Vis, transmission electron microscopy(TEM) and energy dispersive spectrometer(EDS). pRAI targets cancer cells with AS1411 to produce singlet oxygen for PDT and photothermal effect for PTT upon near-infrared(NIR) light irradiation. Since pRGO is decorated with several AS1411-ICG molecules, the pRGO-AS1411-ICG conjugate yields enhanced binding and therapeutic effect by the added ability to carry multiple photosensitizers. Consequently, pRAI offers a remarkably improved and synergistic therapeutic effect on cells.

Key words: Partially reduced graphene oxide, Nanocomposite, Photothermal therapy, Photodynamic therapy, Tumor cell

中图分类号: 

TrendMD: